524322
KABRADG
Invest Now
Start SIP in
KABRADG
Performance
- Low
- ₹20
- High
- ₹21
- 52 Week Low
- ₹8
- 52 Week High
- ₹21
- Open Price₹21
- Previous Close₹20
- Volume274,561
Investment Returns
- Over 1 Month + 79.11%
- Over 3 Month + 88%
- Over 6 Month + 107.06%
- Over 1 Year + 163.34%
Smart Investing Starts Here Start SIP with Kabra Drugs for Steady Growth!
Kabra Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -45.5
- PEG Ratio
- 1
- Market Cap Cr
- 49
- P/B Ratio
- 2
- Average True Range
- 0.51
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.66
- RSI
- 99.96
- MFI
- 100
Kabra Drugs Financials
Kabra Drugs Technicals
EMA & SMA
Current Price
₹20.83
+
0.99
(4.99%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹15.30
- 50 Day
- ₹12.42
- 100 Day
- ₹10.09
- 200 Day
- ₹7.91
Resistance and Support
20.63
- R3 21.62
- R2 21.22
- R1 21.03
- S1 20.44
- S2 20.04
- S3 19.85
Kabra Drugs Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-06-18 | Others | Inter-alia, to consider 1. New acquisition. 2. New drug license for a Chennai office. 3. Diversification by creating new subsidiary. 4. Other business matters. |
2025-05-30 | Audited Results | |
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-11-04 | Others |
Kabra Drugs F&O
About Kabra Drugs
- NSE Symbol
- KABRADG
- BSE Symbol
- 524322
- Managing Director
- Mr. N Aravind
- ISIN
- INE323K01017
Similar Stocks to Kabra Drugs
Kabra Drugs FAQs
Kabra Drugs share price is ₹20 As on 08 July, 2025 | 19:21
The Market Cap of Kabra Drugs is ₹49.4 Cr As on 08 July, 2025 | 19:21
The P/E ratio of Kabra Drugs is -45.5 As on 08 July, 2025 | 19:21
The PB ratio of Kabra Drugs is 2 As on 08 July, 2025 | 19:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.